§ Same category · GLP-1 / metabolic peptides
Survodutide vs Tesofensine
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Survodutide
3
vendors tracked
from $5.85/mg
Tesofensine
0
vendors tracked
Survodutide
Glucagon/GLP-1 dual agonist
Operational
$58.49
$5.85/mg
In stockOn sale
B
Operational$78.00
$7.80/mg
In stock▲ 33.4% vs best
B-
Watch$95.00
$9.50/mg
In stock▲ 62.4% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Glacier Aminos US | B | Operational | $58.49 On sale | $5.85 | In stock | Buy with code → | |
| EZ Peptides US | B | Operational | $78.00 ▲ 33.4% | $7.80 | In stock | Visit → | |
| Ameano Peptides US | B- | Watch | $95.00 ▲ 62.4% | $9.50 | In stock | Visit → |
Sort:
Last crawl 2026-11-12Sort:
2026-11-12Tesofensine
Triple monoamine reuptake inhibitor
No current listings at 1mg.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.
About Tesofensine
A serotonin-noradrenaline-dopamine reuptake inhibitor studied for obesity. Approved for obesity in Mexico; investigational elsewhere.